The family of Henrietta Lacks settles lawsuit with Novartis over use of her cells, marking a turning point in fight for ...

Amatera’s approach is “2x faster and 10x more cost-effective” than industry standards for developing new varieties of perennials, it claims.

Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

OSE will now pivot to focus on late-stage pipeline development of its cancer vaccine, Tedopi and its anti-inflammatory drug, lusvertikimab.

Dedifferentiated liposarcoma lacks effective IGF-1→PPAR-γ adipogenic signaling due to epigenetic silencing of PPAR-γ2, with ...

The global oncology market is projected to nearly triple from $279.98 billion in 2026 to an estimated $748.17 billion by 2035 ...

PHCbi will exhibit LiCellGrow™ at the 25th Congress of the Japanese Society for Regenerative Medicine, March 19-20 at the Kobe International Conference Center and Kobe International Exhibition Center ...

US battery developer Lyten has announced the completion of its acquisition of Northvolt Ett and Ett Expansion (Skellefteå, ...

Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions, Inc. Q4 2025 ...

It’s the second settlement in lawsuits filed by the estate that accused biomedical businesses of reaping rewards from a racist medical system that took advantage of Black patients like Lacks.

Anticipated mid-60% range, flat year over year, impacted by ongoing bag yield issues and product mix, with improvement ...